D-0083-2021 Class II Terminated
FDA drug recall D-0083-2021 was initiated by Milbar Laboratories, Inc. on October 9, 2020 and is designated Class II. Reason for recall: GMP Deviations The recall status is terminated (terminated January 4, 2023). Affected quantity: 4,878 tubes.
Recall Details
- Product Type
- Drugs
- Report Date
- November 25, 2020
- Initiation Date
- October 9, 2020
- Termination Date
- January 4, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4,878 tubes
Product Description
DCL Active Mattifying Cleanser (Salicylic Acid 2%), 125mL/4.2 fl.oz. Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA, UPC 357486509627
Reason for Recall
GMP Deviations
Distribution Pattern
Product was distributed throughout the United States, including Puerto Rico and internationally.
Code Information
Lot # FW937, Exp. Date Jun-22